Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab

Monoclonal antibody (mAb) drugs have been widely used for treating tumor necrosis factor α (TNFα)-related diseases for over 10 years. Although their action has been hypothesized to depend in part on their ability to bind precursor cell surface TNFα, the precise mechanism and the epitope bound on TNF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liang, Shuaiyi, Dai, Jianxin, Hou, Sheng, Su, Lishu, Zhang, Dapeng, Guo, Huaizu, Hu, Shi, Wang, Hao, Rao, Zihe, Guo, Yajun, Lou, Zhiyong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2013
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650416/
https://ncbi.nlm.nih.gov/pubmed/23504311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.433961
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados